These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12373829)

  • 1. [Progress in the field of neurology in the last 100 years: Triplet repeat diseases].
    Tashiro K; Sasaki H
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2263-7. PubMed ID: 12373829
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling human trinucleotide repeat diseases in Drosophila.
    Yu Z; Bonini NM
    Int Rev Neurobiol; 2011; 99():191-212. PubMed ID: 21906541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic testing of triplet repeat disease].
    Tanaka H
    Nihon Rinsho; 1999 Dec; 57 Suppl():696-9. PubMed ID: 10778222
    [No Abstract]   [Full Text] [Related]  

  • 4. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenetics in art.
    Emery AE
    Int Rev Neurobiol; 2006; 74():235-40. PubMed ID: 16730517
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutics development for triplet repeat expansion diseases.
    Di Prospero NA; Fischbeck KH
    Nat Rev Genet; 2005 Oct; 6(10):756-65. PubMed ID: 16205715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1.
    Nussbaum R; Auburger G
    Nat Neurosci; 2000 Feb; 3(2):103-4. PubMed ID: 10649562
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of polyglutamine endolysis followed by pyroglutamate formation in the pathogenesis of triplet repeat/polyglutamine-expansion diseases.
    Saido TC
    Med Hypotheses; 2000 Mar; 54(3):427-9. PubMed ID: 10783480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unusual structure and its biological implications of GGA triplet repeat DNA].
    Katahira M
    Tanpakushitsu Kakusan Koso; 2002 Feb; 47(2):139-44. PubMed ID: 11840677
    [No Abstract]   [Full Text] [Related]  

  • 10. Making degeneration specific.
    Narasimhan K
    Nat Med; 2001 Nov; 7(11):1184. PubMed ID: 11689879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human hereditary disorders caused by expansion of triplet repeats].
    Yamada M
    Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):1181-7. PubMed ID: 11436308
    [No Abstract]   [Full Text] [Related]  

  • 12. Late-onset HMSN 2: further evidence of genetic heterogeneity.
    Vein AA
    Neurology; 2009 May; 72(18):1620-1; author reply 1621. PubMed ID: 19414735
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurodegenerative Huntington-like disorder.
    Bohlega S; Al-Tahan A; Kambouris M; Divakaran M
    Mov Disord; 2001 May; 16(3):533-4. PubMed ID: 11391753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: Dentatorubral-pallidoluysian atrophy].
    Tsuji S
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2296-301. PubMed ID: 12373836
    [No Abstract]   [Full Text] [Related]  

  • 15. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.
    Gunawardena S; Goldstein LS
    Arch Neurol; 2005 Jan; 62(1):46-51. PubMed ID: 15642849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the field of neurology in the last 100 years: Outbreak of beriberi and neurology].
    Nakamura S
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2253-6. PubMed ID: 12373827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in understanding of clinical presentations and molecular mechanisms of triplet repeat diseases].
    Tsuji S
    Nihon Rinsho; 1999 Apr; 57(4):778-86. PubMed ID: 10222765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
    Yamada M; Tan CF; Inenaga C; Tsuji S; Takahashi H
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):665-75. PubMed ID: 15541006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the field of neurology in the last 100 years: Therapeutics for neurological diseases].
    Shinohara Y
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2284-8. PubMed ID: 12373834
    [No Abstract]   [Full Text] [Related]  

  • 20. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.